About this trial
The DHEAL-COM-OP study is characterized as a feasibility study. The general objective is to evaluate the improvement in the physical performance of patients with osteoporosis detected through the Performance-Oriented Mobility Assessment (POMA) scale, following a rehabilitation intervention integrated with the BTS TELEREHAB technology.
Eligibility criteria
Qualifiers
Patients with a positive MOC for osteoporosis without a history of major fractures (femur and vertebrae);
Functional Ambulation Category (FAC) score ≥ 3;
Stability of drug treatment for at least 1 month;
Maintaining an upright position independently > 30";
Disqualifiers
Myocardial infarction or stroke within 6 months;
Painful arthritis, spinal stenosis, amputation, painful foot lesions, or neuropathy that limits balance and mobility;
Uncontrolled hypertension
Metastatic cancer or immunosuppressive therapy;
Trial design
Treatments tested in this trial
- Telerehabilitation
- Usual care
Treatment groups
Sponsors and collaborators
Istituto Nazionale di Ricovero e Cura per Anziani
Lead sponsor
Ministry of Health, Italy
Collaborator